Propanc Biopharma, Inc. (PPCB) stock

PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30

$1.94+0.02 (+1.09%)

Close on Nov 13, 2026Market cap $12.29MP/E –Yield –

Propanc Biopharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Propanc Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?